Neuropathology and virology of HIV associated dementia

Reviews in Medical Virology

Volumn 6, Issue 3, 1996, Pages 141-150

  Fujimura, Robert K ^a   Bockstahler, Larry E ^b   Goodkin, Karl ^a   Werner, Thomas ^c   Brack Werner, Ruth ^c   Shapshak, Paul ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL INVASION; DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NEUROPATHOLOGY; REVIEW; VIROLOGY; VIRUS PATHOGENESIS;

EID: 0029844669     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1654(199609)6:3<141::AID-RMV141>3.0.CO;2-1     Document Type: Review

References (109)

1. Resnick, L., Berger, J. R., Shapshak, P. and Tourtellotte, W. W. (1988). Early penetration of the blood-brain barrier by HTLV-III/LAV. Neurology 38, 8, 9-15.
2. Singer, E. J., Syndulko, K., Fahy-Chandon, B. N. et al. (1994). Cerebrospinal fluid p24 antigen levels and intrathecal immunoglobulin G synthesis are associated with cognitive disease severity in HIV-1 AIDS 8, 197-204.
3. Palmer, D. L., Hjelle, B. L., Wiley, C. A. et al. (1994). HIV-1 infection despite immediate combination antiviral therapy after infusion of contaminated white cells. Am. J. Med. 97, 289-295.
4. Nathanson, N., Cook, D. G., Kolson, D. L. and Gonzalez-Scarano, F. (1994). Pathogenesis of HIV encephalopathy. Ann. NY Acad. Sci. 724, 87-106.
5. Brew, B. J. (1993). The pathogenesis of the neurological complications of HIV-1 infection. Genitourin. Med. 69, 333-340.
6. American Academy of Neurology AIDS Task Force (Working Group). (1991). Nomenclature and research definition for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology 41, 778-785.
7. Navia, B. A., Jordan, B. D. and Price, R. W. (1986). The AIDS dementia complex. I. clinical features. Ann. Neurol. 19, 517-524.
8. Dickson, D. W., Lee, S. C., Hatch, W., Mattiace, L. A., Brosnan, C. F. and Lyman, W. D. (1994). Macrophages and microglia in HIV-related CNS neuropathology. In, HIV, AIDS and the Brain, ed by R. W. Price and S. W. Perry, pp. 99-118. Raven Press, New York.
9. Gendelman, H. E., Lipton, S. A., Tardieu, M., Bukrinsky, M. I. and Nottet, H. S. L. M. (1994). The neuropathogenesis of HIV-1 infection. J. Leukocyte Biol. 56, 389-398.
10. Vitkovic, L., da Cunha, A. and Tyor, W. R. (1994). Cytokine expression pathogenesis in AIDS brain. In, HIV, AIDS and the Brain, ed by R. W. Price and S. W. Perry, pp. 203-222. Raven Press, New York.
11. Goodkin, K. (1988). Psychiatrie disorders in HIV spectrum illness. Texas Med. 84, 55-61.
12. Goodkin, K. (1995). The neuropsychiatric and behavior manifestations of HIV infection. In, Sec IX Clinical Manual on HIV and AIDs. An Up-date, pp. 113-131. Florida Medical Association, Jacksonville FL.
13. Centers for Disease Control (1986). Classification system for human T-lymphotropic virus type III/ lymphadenopathy-associated virus infections. Morbid. Mort. Wkly Rep. 35, 334-339.
14. Centers for Disease Control (1992). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid. Mort. Wkly Rep. 41 (No.RR-17), 1-19.
15. Wilkie, F., Eisdorfer, C., Morgan, R., Loewenstein, D. A. and Szapocznik, J. (1990). Cognition in early human immunodeficiency virus infection. Arch. Neurol 47, 433-440.
16. Centers for Disease Control (1987). Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbid. Mort. Wkly Rep. 36 (Suppl 15), 1s.
17. Lipton, S. A and Gendelman, H. E. (1995). Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332, 934-940.
18. Brew, B. J., Rosenblum, M., Cronin, K. and Price, R. W. (1995). AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann. Neurol 38, 563-570.
19. Newman, S. P., Lunn, S. and Harrison, J. G. (1995). Do asymptomatic HIV-seropositive individuals show cognitive deficit? AIDS 9, 1211-1220.
20. Geleziunas, R., Schipper, H. M. and Wainberg, M. A. (1992). Pathogenesis and therapy of HIV-1 infection of the central nervous system. AIDS 6, 1411-1426.
21. Budka, H., Wiley, C. A., Kleihues, P. et al. (1991). HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1, 143-152.
22. Price, R. W., Brew, B., Sidtis, J., Rosenblum, M., Scheck, A. C. and Cleary, P. (1988). The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 239, 586-592.
23. Petito, C. K., Cho, E-S., Lemann, W., Navia, B. A. and Price, R. W. (1986). Neuropathology of acquired immunodeficiency syndrome (AIDS): autopsy review. J. Neuropathol. Exp. Neurol. 45, 635-646.
24. de la Monte, S. M., Ho, D. D., Schooley, R. T., Hirsch, M. S. and Richardson, E. P. (1987). Subacute encephalomyelitis of AIDS and its relation to HTLV-III infection. Neurology Vol 37 562-569.
25. Kent, T. A., Hillman, G. R., Levin, H. S., Guinto, F., Kaye, A. R. and Casper, K. (1993). Neuroimaging in infection: a preliminary quantitative MRI study and review of the literature. Adv. Neuroimmunol. 3, 129-140.
26. Dal Pan, G. J., McArthur, J. H., Aylward, E. et al. (1992). Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology 42, 2125-2130.
27. Rottenberg, D. A., Moeller, J. R., Strother, S. C. et al. (1987). The metabolic pathway of the AIDS dementia complex. Ann. Neurol. 22, 700-706.
28. McConnell, J. R., Swindells, S., Ong, C. S. et al. (1994). Prospective utility of cerebral proton magnetic resonance spectroscopy in monitoring infection and its associated neurological impairment. AIDS Res. Retrovir. 10, 977-982.
29. Chong, W. K., Sweeney, B., Wilkinson, I. D. et al. (1993). Proton spectroscopy of the brain in HIV infection: Correlation with clinical, immunologic, and MR imaging findings. Neuroradiology 188, 119-124.
30. Seilhean, D., Duyckaerts, C., Vazeux, R. et al. (1993). HIV-1-associated cognitive motor complex-absence of neuronal loss in the cerebral neocortex. Neurology 43, 1492-1499.
31. Everall, I., Luthert, P. and Lantos, P. (1993). A review of neuronal damage in human immunodeficiency virus infection: Its assessment, possible mechanism and relationship to dementia. J. Neuropathol. Exp. Neurol. 52, 561-566.
32. Masliah, E., Achim, C. L., Ge, N., DeTeresa, R. and Wiley, C. A. (1994). Cellular neuropathology in HIV encephalitis. In, HIV, AIDS and the Brain, ed by R. W. Price and S. W. Perry, pp. 119-131. Raven Press, New York.
33. Petito, C. K. and Cash, K. S. (1992). Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome-immunohistochemical localization of serum proteins in postmortem brain. Ann. Neurol. 32, 658-666.
34. Hurwitz, A. A., Berman, J. W. and Lyman, W. D. (1994). The role of the blood-brain barrier in HIV infection of the central nervous system. Adv. Neuroimmunol. 4, 249-256.
35. Falangola, M. E., Hanly, A., Galvao-Castro, B. and Petito, C. K. (1995). HIV Infection of human choroid plexus: a possible mechanism of viral entry into the CNS. J. Neuropathol. Exp. Neurology. 54, 497-503.
36. Harouse, J. M., Wroblewska, Z., Laughlin, M. A., Hickey, W. F., Schonwetter, B. S. and Gonzalez-Scarano, F. (1989). Human choroid plexus cells, can be latently infected with human immunodeficiency virus. Ann. Neurol. 25, 406-411.
37. Achim, C. L., Wang, R., Miners, D. K. and Wiley, C. A. (1994). Brain viral burden in HIV infection. J. Neuropathol. Exp. Neurol. 53, 284-294.
38. Bockstahler, L. E., Werner, T., Festl, H. et al. (1995). Distribution of HIV genomic DNA in brains of AIDS patients. Clin. Dingn. Virol. 3, 61-72.
39. Poland, S. D., Rice, G. P. A. and Dekaban, G. A. (1995). HIV-1 infection of human brain-derived microvascular endothelial cells in vitro. J. AIDS Hum. Retrovir. 8, 437-445.
40. Pert, C. B., Ruff, M. R., Ruscetti, F., Farrar, W. L. and Hill, J. M. (1988). HIV receptor in brain and deduced peptides that block viral infectivity. In Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS,ed. by T. P. Bridge et al., pp. 73-83. Raven Press, New York.
41. Moses, A. V., Bloom, F. E., Pauza, C. D. and Nelson, J. A. (1993). Human immunodeficiency virus infection of human brain capillary endothelial cells occurs via a CD4/galactosyIceramide-independent mechanism. Proc. Natl Acad. Sci. USA 90, 10474-10478.
42. Shapshak, P., Yoshioka, M., Sun, N. C. J. and Schiller, P. (1992). The use of combined in situ hybridization and immunocytochemistry to identify HIV-1 infected cells in brain tissue. Modern. Pathol. 5, 649-654.
43. Gosztonyi, G., Artigas, J., Lamperth, L. and deF. Webster, H. (1994). Human immunodeficiency virus (HIV) distribution in HIV encephalitis: study of 19 cases with combined use of in situ hybridization and immunocytochemistry. J. Neuropathol. Exp. Neurol. 53, 521-534.
44. Nuovo, G. J., Gallery, F., MacConnell, P. and Braun, A. (1994). In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-a RNA in the central nervous system. Am. J. Pathol. 144, 659-665.
45. Shapshak, P., Sun, N., Resnick, L. et al. (1991). HIV propagates in human neuroblastoma cells. J. AIDS 4, 228-237.
46. Tornatore, c., Meyers, K., Atwood, W., Conant, K. and Major, E. (1994). Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 68, 93-102.
47. Brack-Werner, R., Kleinschmidt, A., Ludvigsen A. et al. (1992). Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 6, 273-285.
48. Kleinschmidt, A., Neumann, M., Moller, C., Erfle, V. and Brack-Werner, R. (1994). Restricted expression of HIV-1 in human astrocytes: molecular basis for viral persistence in the CNS. Res. Virol. 145, 147-153.
49. Neumann, M., Felber, B. K., Kleinschmidt, A. et al. (1995). Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in rev function. J. Virol. 69, 2159-2167.
50. Tornatore, C., Chandra, R., Berger, J. R. and Major, E. O. (1994). HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44, 481-487.
51. Saito, Y., Sharer, L.R., Epstein, L. G. et al. (1994). Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 44, 474-481.
52. Blumberg, B. M., Gelbard, H. A. and Epstein, L. G. 1994). HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis. Virus Res. 32, 253-267.
53. Ranki, A., Nyberg, M., Ovod, V. et al. (1995). Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 9, 1001-1008.
54. Kure, K., Weidenheim, K. M., Lyman, W. D. and Dickson, D. W. (1990). Morphology and distribution of HIV-1-positive microglia in subacute AIDS encephalitis: pattern of involvement resembling a multisystem degeneration. Acta Neuropathol. (Berl). 80, 393-400.
55. Masliah, E., Ge, N., Achim, C. L., Hansen, L. A. and Wiley CA. (1992). Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51, 585-593.
56. Wiley, C. A., Schrier, R. D., Nelson, J. A., Lampert, P. W. and Oldstone, M. B. A. (1986). Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl Acad. Sci. USA 83, 7089-7093.
57. Wiley, C. A., Masliah, E. and Achim, C. L. (1994). Measurement of CNS HIV burden and its association with neurologic damage. Adv. Neuroimmunol. 4, 319-325.
58. Aylward, E. H., Henderer, J. D., McArthur, J. C. et al. (1993). Reduced basal ganglia volume in HIV-1 associated dementia complex: results for quantitative neuroimaging. Neurology 43, 2099-2104.
59. Gelman, B. B. (1993). Diffuse microgliosis associated with cerebral atrophy in the acquired immunodeficiency syndrome. Ann. Neurol. 34, 65-70.
60. Post, M. J., Berger, J. R. and Quencer, R. M. (1991). Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology 178, 131-139.
61. Shaw, G. M., Harper, M. E., Hahn, B. H. et al. (1985). HTLV-III infection in brains of children and adults with AIDS encephalopathy. Science 227, 177-182.
62. Cotter, F. E. (1994). The role of polymerase chain reaction in pathology. J. Histotech. 17, 253-259.
63. Pang, S., Koyanagi, Y., Miles, S., Wiley, C., Vinters, H. V. and Chen, I. S. Y. (1990). High levels of unintegrated HIV-1 DNA in brain tissue of AIDs dementia patients. Nature 343, 85-89.
64. Bell, J. E., Busuttil, A., Ironside, J. W. et al. (1993). Human immunodeficiency virus and the brain: investigation of virus load, and neuropathologic changes in pre-AIDS subjects. J. Infect. Dis. 168, 818-824.
65. Boni, J., Emmerich, B. S., Leib, S. L., Wiestier, O. D., Schupbach, J. and Kleihues, P. (1993). PCR identification of HIV-1 DNA sequences in brain tissue of patients with AIDS encephalopathy. Neurology 43, 1813-1817.
66. Sinclair, E. and Scaravilli, F. (1992). Detection of HIV proviral DNA in cortex and white matter of AIDS brains by non-isotopic polymerase chain reaction: correlation with diffuse poliodystrophy. AIDS 6, 925-932.
67. Sinclair, E., Gray, F., Ciardi, A. and Scaravilli, F. (1994). Immunohistochemical changes and PCR detection of HIV provirus DNA in brains of asymptomatic HIV-positive patients. J. Neuropathol. Exp. Neurol. 53, 43-50.
68. Vazeux, R., Lacroix-Ciaudo, C., Blanche, S. et al. (1992). Low levels of human immunodeficiency virus replication in the brain tissue of children with severe acquired immunodeficiency syndrome encephalopathy. Am J Pathol. 140, 137-144.
69. Fujimura, R. K. and Bockstahler, L. E. (1995). PCR method for determining ratios of HIV proviral DNA to cellular genomic DNA in brain tissue of HIV-infected patients. J. Vir. Method 55, 309-325.
70. Oberfield, S. E., Cowan. L., Levine. L. S. et al. (1994). Altered cortisol response and hippocampal atrophy in pediatric HIV disease. J. AIDS 7, 57-62.
71. Brenneman, D. E., McCune, S. K., Mervis, R. F. and Hill, J. M. (1994). gp120 as an etiologic agent for NeuroAIDS: Neurotoxicity and model systems. Adv. Neuroimmunol. 4, 157-165.
72. Sabatier, J-M., Vives, E., Mabrouk, K. et al. (1991). Evidence for neurotoxic activity of tat from human immunodeficiency virus type 1. J. Virol. 65, 961-942.
73. Werner, T., Ferroni, S., Saermark, T. et al. (1991). HIV-1 nef protein exhibits structural and functional similarity to scorpion peptides interacting with K+ channels. AIDS 5, 1301-1308.
74. Glass, J. D., Wesselingh, S. L., Seines, O. A. and McArthur, J. C. (1993). Clinical-neuropathologic correlation in HIV-associated dementia. Neurology 43, 2230-2237.
75. Tyor, W. R., Wesselingh, S. L., Griffin, J. W., McArthur, J. C. and Griffin, D. E. (1995). Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J. AIDS Hum. Retrovirol. 9, 379-388.
76. Yoshioka, M., Bradley, W. G., Shapshak, P. et al. (1995). Role of immune activation and cytokine expression in HIV-1 associated neurologic diseases. Adv. Neuroimmun. 5, 335-358.
77. Petito, C. K. and Roberts, B. (1995). Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146, 1121-1130.
78. Lipton, S. A. (1992). Models of neuronal injury in AIDS: another role for the NMDA receptor? Trends Neurosci. 15, 75-79.
79. Posti, I. and Pakkari, I. (1995). Nitric oxide-based possibilities for pharmacotherapy. Ann. Med. 27, 407-420.
80. Roederer, M., Staal, F. J. T., Raju, P. A. et al. (1990). Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc. Natl Acad. Sci. USA 87, 4884-4888.
81. Tornatore, C., Nath, A., Amemiya, K. and Major, E. O. (1991). Persistent human immunodeficiency virus type-1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor-alpha and interleukin-1-beta. J. Virol. 65, 6094-6100.
82. Vassalli, P. (1992). The pathophysiology of tumor necrosis factors. Ann. Rev. Immunol. 10, 411-452.
83. Vitkovic, L., Chatham, J. J. and da Cunha, A. (1995). Distinct expressions of three cytokines by IL-1-stimulated astrocytes in vitro and in AIDS brain. Brain, Behavior, and Immunity 9, 378-388.
84. Wilt, S. G., Milward, E., Zhou, J. M. et al. (1995). In vitro evidence for a dual role of tumor necrosis factor-α in human immunodeficiency virus type 1 encephalopathy. Ann. Neurol. 37, 381-394.
85. Yeung, M. C., Pulliam, L. and Lau, A. S. (1995). The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 9, 137-143.
86. Wesselingh, S. L., Power, C., Glass, J. D. et al. (1993). Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia. Ann. Neurol. 33, 576-582.
87. Beck, K. D., Valverde, J., Alexi, T. et al. (1995). Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339-341.
88. Schena, M., Shalon, D., Davis, R. W. and Brown, P. O. (1995). Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470.
89. Velculescu, V. E., Zhang, I., Vogelstein, B. and Kinzler, K. W. (1995). Serial analysis of gene expression. Science 270, 484-487.
90. Goodenow, M., Huert, T., Saurin, W., Kwok, S., Sninsky, J. and Wain-Hobson, S. (1989). HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. J. AIDS 2, 344-352.
91. Hahn, B. H., Shaw, G. M., Taylor, M. E. et al. (1986). Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science 232, 1548-1553.
92. Meyerhans, A., Cheynier, R., Albert, J. et al. (1989). Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 58, 901-910.
93. Shapshak, P., Nagano, I., Xin, K. et al. (1995). HIV-1 heterogeneity and cytokines neuropathogenesis. In, The Brain Immune Axis and Substance Abuse,ed. by B. Sharp et al., pp. 225-238. Plenum Press, New York.
94. Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H.V. and Chan, I. S. Y. (1987). Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236, 819-822.
95. Li, Y., Kappes, J. C., Conway, J. A., Price, R., Shaw, G. M. and Hahn, B. (1991). Molecular characteriz ation of HIV-1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes. J. Virol. 65, 3973-3985.
96. Liu, Z-Q., Wood, C., Levy, J.A. and Cheng-Mayer, C. (1990). The viral envelope gene is involved in macrophage tropism of a human immunodeficiency virus type 1 strain isolated from brain tissue. J. Virol. 64, 6148.
97. Cheng-Mayer, C., Weiss, C., Seto, D. and Levy, J. A. (1989). Isolates of human immunodeficiency virus type 1 from the brain may constitute a special group of the AIDS virus. Proc. Natl Acad. Sci. USA 86, 8575-8579.
98. Epstein, L. G., Kuiken, C., Blumberg, B. M. et al. (1991). V3 domain variation in brain and spleen of children with AIDS: Tissue-specific evolution within host-determined quasispecies. Virology 180, 583-590.
99. Korber, B. T., Kunstman, K. J., Patterson, B. K. et al. (1994). Genetic differences between blood- and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J. Virol. 68, 7467-7481.
100. Power, C., McArthur, J. C., Johnson, R. T. et al. (1994). Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J. Virol. 68, 4643-4649.
101. Schmid, P., Conrad, A., Syndulko, K. et al. (1994). Quantifying proviral DNA using the polymerase chain reaction on cerebrospinal fluid and blood of seropositive individuals with and without neurologic abnormalities. J. AIDS 7, 777-788.
102. Shapshak, P., Crandall, K. A., Xin, K. Q. et al. (1996). HIV-1 Neuropathogenesis and abused drugs current views: problems and solutions. In, Advances in Experimental Medicine and Biology,ed. by H. Freedman et al. (In press).
103. Xin, K-Q., Shapshak, P., Kawamoto, S., Nagano, I., McCoy, C. B. and Okuda, K. (1995). Highly divergent env sequences of HIV-1 B subtype with two novel V3 loop motifs detected in an AIDS patient in Miami, Florida. AIDS Res. Hum. Retrovir. 11, 1139-1141.
104. Li, Y., Hui, H., Burgess, C. J. et al. (1992). Complete nucleotide sequence, genome organization, and biological properties of human immunodeficiency virus type 1 in vivo: evidence for limited defectiveness and complementation. J. Virol. 66, 6587-6600.
105. Keys, B., Daris, J., Fadeel, B. et al. (1993). V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 196, 475-483.
106. Pang, S., Vinters, H. V., Akashi, T., O'Brien, W. A. and Chen, I. S. Y. (1991). HIV-1 env sequence variation in brain tissue of patients with AIDS-related neurologic disease. J. AIDS 4, 1082-1092.
107. Briant, L., Fuel, J., Wade, C. M., Leigh Brown, A. J and Guyader, M. (1995). Protecting HIV databases - Reply. Nature 378, 243-244.
108. Korber, B. T. M., Learn, G., Mullins, J. I., Hahn, B. H. and Wolinsky, S. M. (1995). Protecting HIV data-bases. Nature 378, 242-243.
109. Learn, G., Korber, B. T. M., Folley, B., Hahn, B. H., Wolinsky, S.M. and Mullins, J. I. (1996). Maintaining the integrity of human immunodeficiency virus sequences databases. J. Virol. (submitted).